Hancock Jaffe Changes Name To enVVeno, Drops Cardiac Device To Focus On Venous Disease
The company will focus on developing its VenoValve system to treat chronic venous insufficiency and a second product for venous disease.
You may also be interested in...
The new public offering will fund the US pivotal trial of the company’s VenoValve device to treat chronic deep venous insufficiency in the legs.
Nicholas co-founded Boston Scientific in 1979 with John Abele. He served as the company’s CEO from 1979 until 1999 and as chairman until 2016.
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights AI trends in medtech, Exec Chats with iRhythm and medical robotics authority Moshe Shoham, and key FDA updates.